300 Cost to Correct International Normalized Ratio Among Patients With Warfarin-Associated Major Bleeding in Clinical Practice

To assess differences in total inpatient costs among patients whose international normalized ratio (INR) remained uncorrected versus corrected following use of fresh frozen plasma in the management of warfarin-associated major bleeding. A retrospective database analysis was undertaken using electronic medical record data from a large integrated health system. Patients who received fresh frozen plasma between 01/01/2004 and 12/31/2010, and who...